Cabot Corporation (NYSE:CBT) Receives Consensus Rating of “Hold” from Brokerages

Shares of Cabot Corporation (NYSE:CBT) have been given a consensus rating of “Hold” by the seven brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $89.00.

A number of research analysts have recently commented on CBT shares. JPMorgan Chase & Co. boosted their price target on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research report on Friday, August 7th. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a report on Sunday, August 9th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research report on Friday, August 21st. UBS Group cut their price target on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a research note on Wednesday, August 5th. Finally, Truist Financial set a $100.00 price objective on shares of Cabot in a research report on Wednesday, August 5th.

Cabot Stock Performance

Shares of CBT stock opened at $79.83 on Monday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. Cabot has a one year low of $58.33 and a one year high of $94.53. The company has a fifty day moving average price of $85.86 and a two-hundred day moving average price of $81.56. The stock has a market cap of $4.12 billion, a P/E ratio of 22.49, a P/E/G ratio of 10.34 and a beta of 0.83.

Cabot (NYSE:CBT) last posted its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, topping analysts’ consensus estimates of $1.66 by $0.01. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The firm had revenue of $982.00 million during the quarter, compared to analysts’ expectations of $943.16 million. During the same quarter in the prior year, the business earned $1.90 earnings per share. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, equities analysts predict that Cabot will post 6.35 EPS for the current year.

Cabot Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 11th. Shareholders of record on Friday, August 28th were paid a dividend of $0.4725 per share. The ex-dividend date of this dividend was Friday, August 28th. This represents a $1.89 annualized dividend and a yield of 2.4%. Cabot’s payout ratio is 53.24%.

Insider Activity

In other news, CEO Sean Keohane sold 134,895 shares of the company’s stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $85.00, for a total value of $11,466,075.00. Following the completion of the transaction, the chief executive officer directly owned 404,134 shares in the company, valued at approximately $34,351,390. This represents a 25.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In the last three months, insiders sold 229,597 shares of company stock valued at $19,646,746. 3.08% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Cabot

Institutional investors have recently bought and sold shares of the stock. Public Employees Retirement System of Ohio grew its holdings in Cabot by 15.4% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,202 shares of the specialty chemicals company’s stock worth $80,000 after acquiring an additional 160 shares during the last quarter. Janney Montgomery Scott LLC grew its stake in shares of Cabot by 2.6% in the fourth quarter. Janney Montgomery Scott LLC now owns 6,298 shares of the specialty chemicals company’s stock worth $417,000 after purchasing an additional 161 shares during the last quarter. Allianz Asset Management GmbH boosted its holdings in Cabot by 0.4% in the second quarter. Allianz Asset Management GmbH now owns 46,692 shares of the specialty chemicals company’s stock valued at $4,241,000 after acquiring an additional 174 shares in the last quarter. Parallel Advisors LLC increased its position in Cabot by 10.5% during the 1st quarter. Parallel Advisors LLC now owns 1,843 shares of the specialty chemicals company’s stock valued at $139,000 after purchasing an additional 175 shares during the period. Finally, Swiss Life Asset Management Ltd raised its holdings in Cabot by 3.6% in the 2nd quarter. Swiss Life Asset Management Ltd now owns 6,147 shares of the specialty chemicals company’s stock worth $558,000 after purchasing an additional 212 shares in the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Cabot Company Profile

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company. Its products are used by manufacturers in transportation, infrastructure, energy, electronics, consumer goods, and other industrial markets.

Cabot’s Reinforcement Materials business produces carbon black and other materials used to reinforce tires, automotive components, industrial rubber products, and plastics. Its Performance Chemicals business supplies specialty carbon blacks, fumed metal oxides, inkjet colorants, conductive compounds, masterbatch products, and related materials used to modify the color, conductivity, strength, durability, and processing characteristics of finished products.

Founded in 1882, Cabot operates research, manufacturing, and commercial facilities serving customers in North America, South America, Europe, Asia, and other international markets.